Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

400
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

194
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
194
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Introduction to Electrolytes01:33

Introduction to Electrolytes

12.5K
In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
12.5K
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

915
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
915

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for undercorrection in severe hyponatremia: a post-hoc analysis of the SALSA trial.

Kidney research and clinical practice·2026
Same author

Dietary Administration of a Soybean Fermented Preparation Reshapes Gut Microbial Community Structure and Colonic Mucosal Features in BALB/c Mice.

Microorganisms·2026
Same author

Real-world treatment switching and healthcare costs of onabotulinumtoxinA and calcitonin gene-related peptide monoclonal antibodies in Medicare patients with chronic migraine: a retrospective claims analysis.

Journal of medical economics·2026
Same author

Influence of wastewater discharge and seasonal variability on synthetic musk compounds in major Korean rivers.

Ecotoxicology and environmental safety·2025
Same author

Spatiotemporal trends and ecological risks of neonicotinoid insecticides in Korean surface waters.

Journal of hazardous materials·2025
Same author

Nationwide profiling and source identification of organophosphate esters in Korean surface waters using target, suspect, and non-target HRMS analysis.

Chemosphere·2024
Same journal

Korean Society of Nephrology 2025 Evidence-Based Clinical Practice Guideline for Continuous Kidney Replacement Therapy.

Electrolyte & blood pressure : E & BP·2026
Same journal

The Proposed Chronic Kidney Disease Management Act in Korea: A Step Toward a National Strategy for Kidney Disease Prevention and Care.

Electrolyte & blood pressure : E & BP·2026
Same journal

Advances in Hyperkalemia Management and the Emerging Role of Sodium Zirconium Cyclosilicate.

Electrolyte & blood pressure : E & BP·2026
Same journal

Relationship Between Cardiac Autonomic Control and Intradialytic Hypotension in Senegalese Chronic Hemodialysis Patients: A Single Center Prospective Study.

Electrolyte & blood pressure : E & BP·2026
Same journal

Unusual Presentation of Hyponatremia: Persistent Hiccups.

Electrolyte & blood pressure : E & BP·2026
Same journal

Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors for Uricosuria.

Electrolyte & blood pressure : E & BP·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

12.7K

Magnesium metabolism.

Jang Won Seo1, Tae Jin Park1

  • 1Department of Internal Medicine, College of Medicine and Kidney Research Institute, Hallym University, Seoul, Korea.

Electrolyte & Blood Pressure : E & BP
|January 25, 2014
PubMed
Summary
This summary is machine-generated.

Magnesium homeostasis involves intestinal absorption and renal excretion, with key roles for claudin-16 and TRPM6 channels. Understanding these pathways is crucial for managing magnesium balance and related disorders.

Keywords:
homeostasismagnesiumparacellular transporttranscellular transporttransient receptor potential channels

More Related Videos

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
11:52

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

4.1K
One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

16.2K

Related Experiment Videos

Last Updated: May 3, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

12.7K
Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
11:52

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

4.1K
One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

16.2K

Area of Science:

  • Nephrology
  • Molecular Biology
  • Human Physiology

Background:

  • Magnesium is the second most abundant intracellular cation, vital for numerous cellular functions.
  • Body magnesium balance is regulated by intestinal absorption, bone exchange, and renal excretion.
  • Renal reabsorption, particularly in the thick ascending limb (TAL) and distal convoluted tubule (DCT), is critical for maintaining serum magnesium levels.

Purpose of the Study:

  • To review the mechanisms of intestinal and renal magnesium absorption.
  • To highlight the molecular players involved in magnesium transport, including claudin-16 and TRPM6.
  • To identify current gaps in understanding magnesium homeostasis, specifically the basolateral exit mechanism.

Main Methods:

  • Review of existing literature on magnesium transport and homeostasis.
  • Analysis of genetic studies linking mutations in claudin-16 and TRPM6 to hypomagnesemia.
  • Discussion of the regulation of TRPM6 and its role in epithelial magnesium entry.

Main Results:

  • Passive paracellular magnesium transport in the TAL is linked to claudin-16 mutations, causing familial hypomagnesemia with hypercalciuria.
  • Active transcellular magnesium transport in the DCT involves TRPM6, with defects leading to hypomagnesemia and secondary hypocalcemia.
  • TRPM6 regulates apical magnesium entry and urinary excretion, influenced by factors like acid-base status and estradiol.

Conclusions:

  • Claudin-16 and TRPM6 are essential for renal magnesium reabsorption and maintaining magnesium homeostasis.
  • Defects in these transporters lead to significant clinical disorders characterized by low serum magnesium.
  • The protein responsible for basolateral magnesium exit from epithelial cells remains to be identified, representing a key area for future research.